In February, a presentation was given on Zecuity, a new way to treat migraine headaches which included a patch that delivered medication via an electrical current.  TEVA has suspended manufacturing of this device pending an investigation into complaints of burns and scarring.  The full FDA website announcement can be found at :

 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm504736.htm